Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer

• Publication date

  2017-12-08

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1002/cncr.31227PMID 29315507PMCID PMC5867247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer.

  2018cited by this paper
• Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary.

  2017cited by this paper
• Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.

  2017cited by this paper
• Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

  2017cited by this paper
• Modeling Survival Data Extending The Cox Model

  2016cited by this paper
• Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

  2016cited by this paper
• Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.

  2015cited by this paper
• Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment

  2015cited by this paper
• Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation.

  2014cited by this paper
• Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study.

  2014cited by this paper
• Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

  2014cited by this paper
• Late cardiovascular complications after hematopoietic cell transplantation.

  2014cited by this paper
• Risk of ischemic heart disease in women after radiotherapy for breast cancer.

  2013cited by this paper
• Prevalence of hematopoietic cell transplant survivors in the United States.

  2013cited by this paper
• Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.

  2013cited by this paper
• Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment

  2013cited by this paper
• Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation

  2013cited by this paper
• Adherence to the WCRF/AICR Guidelines for Cancer Prevention Is Associated with Lower Mortality among Older Female Cancer Survivors

  2013cited by this paper
• Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

  2012cited by this paper
• Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia

  2012cited by this paper
• Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors.

  2012cited by this paper
• Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

  2012cited by this paper
• Community-based exercise program effectiveness and safety for cancer survivors

  2012cited by this paper
• Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation

  2011cited by this paper
• Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors.

  2011cited by this paper
• Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation.

  2011cited by this paper
• Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.

  2011cited by this paper
• Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

  2010cited by this paper
• Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial.

  2009cited by this paper
• Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.

  2009cited by this paper
• Trends in Fruit and Vegetable Consumption Among U.S. Men and Women, 1994–2005

  2008cited by this paper
• Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

  2008influential reference
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.

  2005cited by this paper
• Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer.

  2005cited by this paper
• Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.

  2005cited by this paper
• Validation of self-reported complications by bone marrow transplantation survivors

  2000cited by this paper

• Modifiable Risk Factors in Transplant: Lifestyle Advice and Adherence in a Prospective Cohort Study

  2025cites this paper
• Combined lifestyle factors on mortality and cardiovascular disease among cancer survivors: a systematic review and meta-analysis of cohort studies

  2024cites this paper
• Multidisciplinary Management of Morbidities Associated with Chronic Graft-Versus-Host Disease

  2024cites this paper
• Rehabilitation practices during hematopoietic stem cell transplantation: An international survey.

  2024cites this paper
• Cardiac function in long-term survivors of children posthematopoietic stem cells transplantation

  2024cites this paper
• Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation

  2024cites this paper
• International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update

  2024cites this paper
• Assessment of Rehabilitation Practices During Hematopoietic Stem Cell Transplantation in the United States: A Survey

  2024cites this paper
• Cardiotoxicity, Cardioprotection, and Prognosis in Survivors of Anticancer Treatment Undergoing Cardiac Surgery: Unmet Needs

  2023cites this paper
• International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update

  2023cites this paper
• Cardiovascular toxicity from therapies for light chain amyloidosis

  2023cites this paper
• A Comparison of the Physical Activity and Sedentary Behavior between Autologous and Allogeneic Hematopoietic Stem Cell Transplantation Survivors

  2023influential citation
• Sex-Specific Cardiovascular Risks of Cancer and Its Therapies

  2022cites this paper
• Personalizing Heart Failure Care to the Patient With Cancer

  2022cites this paper
• Underdiagnosis and Undertreatment of Modifiable Cardiovascular Risk Factors Among Survivors of Childhood Cancer

  2022cites this paper
• Cardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients

  2022cites this paper
• Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment

  2021cites this paper
• Late Effects After Haematopoietic Stem Cell Transplantation in ALL, Long-Term Follow-Up and Transition: A Step Into Adult Life

  2021cites this paper
• Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer

  2021cites this paper
• Cardiac and arterial complications

  2021cites this paper
• How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation

  2021cites this paper
• Feasibility of a behavioral intervention using mobile health applications to reduce cardiovascular risk factors in cancer survivors: a pilot randomized controlled trial

  2020cites this paper
• Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation

  2020cites this paper
• Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation

  2020cites this paper
• Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.

  2020cites this paper
• Allogeneic hematopoietic cell transplantation; the current renaissance.

  2019cites this paper
• The long noncoding RNA NKILA protects against myocardial ischaemic injury by enhancing myocardin expression via suppressing the NF-κB signalling pathway.

  2019cites this paper
• Prediction of cardiovascular disease among hematopoietic cell transplantation survivors.

  2018cites this paper
• Comorbidities, age, and other patient-related predictors of allogeneic hematopoietic cell transplantation outcomes

  2018cites this paper